Skip Navigation

Toxicological Sciences 2004 81(1):253; doi:10.1093/toxsci/kfh185
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bloksma, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bloksma, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences vol. 81 no. 1 © Society of Toxicology 2004; all rights reserved.

Letter to the Editor

Nanne Bloksma

Department of Pharmacology and Pathophysiology, Utrecht Institute of Parmaceutical Sciences and Faculty of Biology, Utrecht University, P.O. Box 80082, NL-3508 TB Utrecht, The Netherlands

The first 10% of the full text of this article appears below.

To the Editor:

Ezendam et al. (2004)Go recently reported on effects of the T cell inhibitor, cyclosporin A (CsA), on hexachlorobenzene (HCB)-induced immunopathology in the Brown Norway (BN) rat. . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?